Targeting the sigma-1 receptor with pridopidine induces functional neurorestoration in spinal cord ischemia-reperfusion injury
Naunyn-Schmiedeberg's Archives of Pharmacology · 2025
DOI: 10.1007/s00210-025-03851-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Eman Sweed und 7 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacology Department, Faculty of Medicine, Menoufia University, Menoufia, Egypt. eman.sweed@med.menofia.edu.eg. Hauptthemen laut MEDLINE: Receptors, sigma, Reperfusion Injury, Neuroprotective Agents, Spinal Cord Ischemia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Minufiya University.
Abstract (Originalsprache)
Spinal cord ischemia reperfusion injury (IRI) occurs with an incidence of 1–32%, often leading to paraplegia with limited prevention options. Pridopidine (Prdpn), a highly selective sigma-1 receptor (Sig-1R) agonist, serves as a protein chaperone that is engaged in neuroplasticity and cellular defense. This research aimed to assess the neuroprotective properties of Prdpn in spinal cord IRI in rats and investigate the underlying mechanisms. Forty male Wistar albino rats were randomly allocated into 4 groups: control, sham, IRI, and IRI + Prdpn. Tarlov’s test was used to examine behavioral performance, as well as withdrawal from agonizing stimuli and the placing/stepping reflex (SPR). Biochemical markers, including spinal malondialdehyde (MDA), AOPP, antioxidant GPX, TNF-α and IL-1β, and apoptotic caspase-3, were measured, along with BDNF, GDNF, and Sig-1R gene expression. Histopathological changes in spinal cord tissue were also evaluated. Spinal cord IRI significantly caused neurological deficits, evidenced by lower scores in Tarlov’s test, withdrawal from agonizing stimuli, and SPR. Biochemically, spinal cord IRI led to decreased GPX and increased MDA, AOPP, TNF-α, IL-1β, caspase-3, and GDNF levels, along with downregulated BDNF and Sig-1R gene expression. Histopathologically, spinal cord IRI resulted in greater spinal neuronal degeneration, apoptosis, and demyelination. However, treatment with Prdpn significantly improved behavioral outcomes and partially reversed the biochemical and histopathological alterations. Prdpn improved spinal cord IRI-induced behavioral deficits through its antioxidant, anti-inflammatory, anti-apoptotic, and neurotrophic properties. It suggests promise as a potential treatment option to stop spinal cord IRI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Pharmacology Department, Faculty of Medicine, Menoufia University, Menoufia, Egypt. eman.sweed@med.menofia.edu.eg.
- Clinical Pharmacology Department, Menoufia National University, Menoufia, Egypt. eman.sweed@med.menofia.edu.eg.
- Medical Physiology Department, Faculty of Medicine, Menoufia University, Menoufia, Egypt.
- Medical Physiology Department, Menoufia National University, Menoufia, Egypt.
- Histology and Cell Biology, Faculty of Medicine, Menoufia University, Menoufia, 32511, Egypt.
- AlRyada University for Science and Technology, Menoufia, 32511, Egypt.
ORCID-Profile: Eman Sweed, Suzan A Khodir, Shaimaa Mohamed Motawea, Hala El-Haron, Basma Abdelnaby Mostafa, Mona S Elkholy, Doaa Z M Shebl
Förderung
- Minufiya University
Zitieren
APA
Sweed, E., Khodir, S. A., Motawea, S. M., El-Haron, H., Mostafa, B. A., Elkholy, M. S., Salim, M., & Shebl, D. Z. M. (2025). Targeting the sigma-1 receptor with pridopidine induces functional neurorestoration in spinal cord ischemia-reperfusion injury. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-03851-3
Vancouver
Sweed E, Khodir SA, Motawea SM, El-Haron H, Mostafa BA, Elkholy MS, et al. Targeting the sigma-1 receptor with pridopidine induces functional neurorestoration in spinal cord ischemia-reperfusion injury. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-025-03851-3
BibTeX
@article{Sweed2025,
author = {Sweed, Eman and Khodir, Suzan A and Motawea, Shaimaa Mohamed and El-Haron, Hala and Mostafa, Basma Abdelnaby and Elkholy, Mona S and Salim, Mohammud and Shebl, Doaa Z M},
title = {Targeting the sigma-1 receptor with pridopidine induces functional neurorestoration in spinal cord ischemia-reperfusion injury},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2025},
doi = {10.1007/s00210-025-03851-3}
}
EUVIMED